Skip to main content
logo
AptarGroup, Inc. (ATR)
NYSE: ATR · Real-Time Price · USD
120.43
+0.18 (0.15%)
At close: Oct 7, 2026, 4:00 PM EDT
120.00
-0.43 (-0.36%)
Pre-market: Oct 8, 2026, 4:53 AM EDT

Revenue

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
Aptar Pharma Revenue
1.78B1.74B1.64B
Aptar Beauty Revenue
1.40B1.31B1.23B
Aptar Closures Revenue
751.12M730.26M714.01M
Revenue (Total)
3.93B3.78B3.58B

Adjusted EBITDA

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
Aptar Pharma Adjusted EBITDA
608.49M607.65M568.37M
Aptar Beauty Adjusted EBITDA
159.78M158.77M159.91M
Aptar Closures Adjusted EBITDA
110.84M116.48M114.14M
Corporate & Other Adjusted EBITDA
-64.29M-67.79M-67.50M
Operating Income (Other)
-337.41M-314.06M-278.43M
Operating Income (Total)
477.42M501.04M496.50M

Key Performance Indicators

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
Aptar Pharma Core Sales Growth
3.00%8.00%
Aptar Beauty Core Sales Growth
2.00%-3.00%
Aptar Closures Core Sales Growth
1.00%3.00%
Total Core Sales Growth
2.00%3.00%